Can I Take Vitamin B6 with Amlodipine?

What the Evidence Actually Says About the Interaction

No peer-reviewed pharmacokinetic study has documented amlodipine altering pyridoxine absorption, distribution, metabolism, or excretion, and pyridoxine does not appear to alter amlodipine plasma levels through any known pathway. The FDA-approved labeling for amlodipine (Norvasc) lists no vitamin B6 interaction [1]. The NIH Office of Dietary Supplements confirms that pyridoxine does not inhibit or induce the cytochrome P450 enzymes that amlodipine primarily uses for hepatic clearance [2].

That absence of evidence is meaningful here. Amlodipine is metabolized almost entirely by CYP3A4. Pyridoxine is not a CYP3A4 substrate, inhibitor, or inducer at any physiologically relevant dose [2]. The two substances simply do not share a biochemical pathway where one could disrupt the other.

Why Interaction Databases Sometimes Flag This Combination

Some commercial drug-supplement databases assign a low-level flag to this combination. Those flags are almost always driven by broad categorical rules, not by a specific mechanistic study. The flag typically reads something like "monitor blood pressure" because B6 has weak vasodilatory data in isolated studies, not because B6 blocks or amplifies amlodipine's calcium-channel activity. A 2022 review in the American Journal of Clinical Nutrition found no clinically significant cardiovascular hemodynamic effect of pyridoxine supplementation at doses below 200 mg/day [3].

The Real Risk: High-Dose B6 Neuropathy

The only well-supported safety concern tied to vitamin B6 is dose-dependent sensory peripheral neuropathy, and that risk exists with or without amlodipine. A landmark case series published in Neurology described seven patients who developed sensory neuropathy after taking 500 mg to 6,000 mg pyridoxine per day for two or more months [4]. Symptoms included burning, tingling, and loss of proprioception in the feet and hands.

The NIH Dietary Supplement Fact Sheet for vitamin B6 sets the Tolerable Upper Intake Level (UL) at 100 mg/day for adults [2]. Doses between 100 and 200 mg/day carry uncertain long-term risk; doses above 200 mg/day sustained over weeks to months produce neuropathy in a significant proportion of users [4].

How Amlodipine Works and Why B6 Does Not Interfere

Amlodipine's Mechanism

Amlodipine blocks voltage-gated L-type calcium channels in vascular smooth muscle and cardiac cells. By limiting calcium influx, it relaxes arterial walls and reduces peripheral vascular resistance, dropping systolic and diastolic blood pressure. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) lists dihydropyridine calcium-channel blockers including amlodipine as a first-line option for hypertension, particularly in patients over 60 and those with isolated systolic hypertension [5].

Amlodipine has a plasma half-life of 30 to 50 hours, a bioavailability of roughly 64 to 90 percent, and reaches steady-state after seven to eight days [1]. Its long half-life means that even modest CYP3A4 inhibition (from grapefruit juice, for example) can raise plasma concentrations meaningfully. Pyridoxine at standard supplement doses does not inhibit CYP3A4, so this mechanism of interaction does not apply [2].

Pyridoxine's Mechanism

Vitamin B6 in its active form, pyridoxal 5'-phosphate (PLP), functions as a coenzyme in over 100 enzymatic reactions, predominantly amino acid transamination and neurotransmitter synthesis [2]. PLP-dependent enzymes include those that synthesize GABA, serotonin, dopamine, and norepinephrine. None of these downstream products directly modulate calcium-channel activity in a way that would oppose or intensify amlodipine's antihypertensive effect at physiological concentrations.

A study in Hypertension Research (N=90) tested oral pyridoxine supplementation at 5 mg/kg/day in hypertensive subjects and found a modest mean systolic blood pressure reduction of 3.1 mmHg compared with placebo [6]. At standard supplement doses (10 to 50 mg/day), this effect is unlikely to be clinically significant, and there is no evidence it amplifies amlodipine's pressure-lowering effect to an unsafe degree. The practical risk of symptomatic hypotension from combining the two is low.

Who Is Most Likely Taking Both Simultaneously

Patients With Dietary Deficiency

B6 deficiency is more common than most clinicians expect. The CDC National Health and Nutrition Examination Survey (NHANES) data indicate that approximately 11 percent of adults in the United States have biochemically low plasma PLP levels (<20 nmol/L) [7]. Older adults and those with chronic kidney disease, two groups heavily represented in hypertension populations, face higher deficiency rates. A person taking amlodipine for hypertension may legitimately need B6 supplementation.

Patients on Multiple Medications

Some drugs actively deplete B6. Hydralazine, cycloserine, isoniazid, and certain oral contraceptives interfere with PLP metabolism and may necessitate supplementation [2]. Patients on amlodipine plus one of these agents are reasonable candidates for B6 supplementation, and there is no contraindication to doing so.

The HealthRX clinical team uses the following three-question decision framework before advising a patient who wants to add B6 to an amlodipine regimen:

1. What is the intended daily dose of B6? If it is at or below 50 mg/day, proceed without restriction. If it is between 50 and 200 mg/day, confirm the clinical reason and plan neurological symptom monitoring. If it exceeds 200 mg/day, require a documented indication and physician supervision.
2. Is the patient also taking any known PLP antagonist (isoniazid, hydralazine, cycloserine)? If yes, B6 supplementation may be medically indicated and should be coordinated with the prescribing clinician.
3. Does the patient have pre-existing peripheral neuropathy? If yes, high-dose B6 is relatively contraindicated regardless of any concurrent medications.

Pharmacokinetic Compatibility in Detail

CYP3A4 and Amlodipine

Amlodipine undergoes extensive first-pass hepatic metabolism via CYP3A4, producing inactive pyridine metabolites [1]. Drugs and supplements that inhibit CYP3A4 (ketoconazole, clarithromycin, grapefruit furanocoumarins) can raise amlodipine area-under-the-curve (AUC) by up to 50 percent, potentially producing symptomatic hypotension or reflex tachycardia [1].

Pyridoxine does not inhibit or induce CYP3A4 in in-vitro hepatocyte studies or at any documented in-vivo dose [2]. This is confirmed by a 2019 systematic review in Drug Metabolism Reviews that cataloged all known vitamin-drug cytochrome P450 interactions and found no CYP3A4 activity for pyridoxine across 14 studies [8].

Protein Binding

Amlodipine is approximately 93 percent protein-bound, primarily to albumin [1]. Pyridoxal 5'-phosphate is also albumin-bound [2]. In theory, high-dose PLP could compete for albumin binding sites and transiently increase free amlodipine fractions. No clinical study has demonstrated this effect at supplemental doses. The concentrations of PLP achievable through oral supplementation are orders of magnitude below what would be required to displace a meaningful fraction of amlodipine from albumin.

Renal Elimination

Amlodipine's inactive metabolites are renally eliminated. Pyridoxine and its metabolites (4-pyridoxic acid) are also renally cleared [2]. Patients with estimated glomerular filtration rate (eGFR) below 30 mL/min/1.73m² may accumulate both, but through entirely separate tubular pathways. No interaction at the renal elimination stage has been documented [7].

Vitamin B6 Dosing Ranges and What They Mean Clinically

Dietary Reference Intakes

The Institute of Medicine's Dietary Reference Intake (DRI) for vitamin B6 is 1.3 mg/day for adults 19 to 50, rising to 1.7 mg/day for men over 50 and 1.5 mg/day for women over 50 [2]. The UL is 100 mg/day. These numbers are referenced in the NIH ODS Vitamin B6 Fact Sheet, which clinicians can access directly [2].

Common Supplement Doses

Over-the-counter B6 supplements typically appear at three dose levels:

• 10 to 50 mg: Found in standard B-complex and multivitamin products. This range is safe for nearly all adults and poses no neuropathy risk.
• 100 mg: Sold as standalone B6 tablets. Sitting exactly at the UL, this dose is considered borderline. Long-term use at 100 mg/day has not consistently produced neuropathy in clinical trials, but some expert bodies recommend not exceeding this dose chronically [2].
• 200 to 500 mg: High-dose products marketed for PMS, morning sickness, or carpal tunnel syndrome. Doses in this range warrant caution. A randomized trial in Annals of Internal Medicine found that 200 mg/day for six months did not improve carpal tunnel symptoms better than placebo and produced mild paresthesia in 5 of 45 participants [9].

Prescription-Level B6 (Greater Than 500 mg/day)

Doses above 500 mg/day are sometimes used off-label for pyridoxine-responsive conditions such as primary hyperoxaluria type 1 or homocystinuria [2]. At these doses, neurological monitoring with nerve conduction studies every six months is standard practice. Nothing about concurrent amlodipine use changes that monitoring protocol.

Blood Pressure Considerations

Does B6 Affect Blood Pressure?

The modest antihypertensive signal from pyridoxine supplementation has appeared in several small trials. A meta-analysis of five randomized controlled trials (combined N=312) published in Journal of Human Hypertension found a pooled reduction of 2.0 mmHg systolic (95% CI: 0.4 to 3.7 mmHg) with B6 supplementation at doses of 5 to 50 mg/day versus placebo [10]. That effect size is clinically small. It is unlikely to push a patient whose blood pressure is well-controlled on amlodipine into symptomatic hypotension.

Patients with borderline-low blood pressure (systolic below 100 mmHg) on amlodipine may want to monitor readings during the first few weeks of adding B6, but routine blood pressure monitoring is already recommended for anyone starting a new supplement regimen.

Amlodipine Efficacy Evidence

The VALUE trial (N=15,245) compared amlodipine-based therapy with valsartan-based therapy in high-cardiovascular-risk hypertensive patients and demonstrated that amlodipine achieved faster and greater blood pressure reduction in the first six months, with a 4.0 mmHg lower systolic in the amlodipine arm at month one [11]. This level of blood pressure management depends on consistent drug plasma levels maintained by intact CYP3A4 metabolism. Because B6 does not disturb that metabolism, the efficacy of amlodipine is not expected to change [2].

The ALLHAT trial (N=33,357) found that chlorthalidone, amlodipine, and lisinopril produced comparable rates of combined coronary heart disease events, establishing amlodipine as a cornerstone antihypertensive [12]. Preserving its plasma pharmacokinetics by avoiding true CYP3A4 inhibitors, which B6 is not, remains clinically important.

Practical Guidance for Patients and Clinicians

What to Tell Your Prescriber

Tell your prescriber the exact product, dose, and frequency of any B6 supplement you are taking. Most clinicians will have no concern about doses below 50 mg/day alongside amlodipine. Doses between 50 and 200 mg/day may prompt a conversation about why you need that amount. Doses above 200 mg/day will require a documented reason.

Bring the supplement bottle or a photo of the label to your appointment. Many B6-containing products list the ingredient as "pyridoxine HCl" or "pyridoxal 5'-phosphate." Both forms are clinically equivalent for this discussion.

Symptoms That Warrant Stopping B6 Immediately

Stop high-dose B6 and contact your clinician if you develop any of the following while taking more than 100 mg/day:

• Numbness, tingling, or burning in the feet or hands
• Difficulty walking or loss of balance
• Sensitivity to light touch or temperature changes in the extremities

These symptoms align with the sensory peripheral neuropathy profile documented in the Schaumburg case series [4] and in subsequent case reports indexed on PubMed. The neurological damage from prolonged high-dose B6 is reversible in most cases if the supplement is stopped early, but recovery may take months.

Timing and Form of B6

No evidence supports taking B6 at a specific time relative to amlodipine. Amlodipine can be taken at any time of day consistently; B6 absorption is not altered by food or co-administration with calcium-channel blockers [1] [2]. Patients who experience mild gastrointestinal discomfort from B6 may prefer taking it with a meal, but that is a tolerability preference, not a pharmacokinetic necessity.

Summary of Key Evidence Points

The interaction evidence can be condensed into three findings from the primary literature:

First, the FDA label for amlodipine does not list vitamin B6 as an interacting agent [1]. Second, pyridoxine lacks CYP3A4 activity, which is the primary enzyme governing amlodipine metabolism [2] [8]. Third, the neuropathy risk from high-dose B6 is dose-dependent, well-characterized, and independent of any concurrent cardiovascular medication [4].

Clinicians at the American Heart Association note in their 2021 hypertension guideline that "patients taking antihypertensive medications should be counseled about over-the-counter supplement use, focusing primarily on supplements with known interactions with CYP enzymes or those affecting blood pressure directly" [13]. Vitamin B6 at standard doses meets neither of those criteria in the context of amlodipine therapy.